USRE38131EExpiredUtility
Reagent for measurement of leukocytes and hemoglobin concentration in blood
Est. expiryApr 18, 2017(expired)· nominal 20-yr term from priority
Y10T436/108331Y10T436/25125Y10T436/101666G01N 33/721Y10T436/25G01N 33/5094Y10T436/2525Y10T436/10Y10T436/107497
81
PatentIndex Score
23
Cited by
13
References
6
Claims
Abstract
A reagent for measurement of leukocytes and hemoglobin concentration in the blood includes a cationic surfactant in an amount sufficient to lyse erythrocytes and denature hemoglobin, at least one of the following hemoglobin stabilizers: (a) sulfosalicylic acid, or its salt, in an amount effective for promoting the conversion of hemoglobin into methemoglobin, (b) 0.2 to 10.0 g/L of a water-soluble chelating agent having a nitrogen atom and a carboxyl group, and (c) piperazine, or its salt, in an amount effective for promoting the conversion of hemoglobin into methemoglobin, and a buffer for maintaining pH at 4 to 6.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A reagent for measurement of leukocytes and hemoglobin concentration in blood, said reagent consisting essentially of:
(1) a cationic surfactant in an amount sufficient to lyse erythrocytes and denature hemoglobin,
(2) at least one hemoglobin stabilizer selected from the group consisting of the following (a), (b) and (c):
(a) sulfosalicylic acid, or its salt, in an amount effective for promoting the conversion of hemoglobin into methemoglobin,
(b) 0.2 to 10.0 g/L of a water-soluble chelating agent having a nitrogen atom and a carboxyl group, and
(c) piperazine, or its salt, in an amount effective for promoting the conversion of hemoglobin into methemoglobin, and
(3) a buffer for maintaining pH at 4 to 6.
2. The reagent as claimed in claim 1 , wherein said water-soluble chelating agent is a salt of EDTA.
3. The reagent as claimed in claim 1 , wherein the amount effective for promoting the conversion of hemoglobin into methemoglobin is 0.2 to 10.0 g/L for sulfosalicylic acid or its salt, and 0.2 to 10.0 g/L for piperazine or its salt.
4. A reagent for measurement of blood leukocyte counts and hemoglobin concentrations by conversion to methemoglobin, said reagent containing:
(1) a cationic surfactant in an amount effective to lyse erythrocytes and denature hemoglobin,
(2) at least one or more hemoglobin stabilizers present in a total amount sufficient to convert the hemoglobin to methemoglobin, said at least one or more stabilizers being selected from the group consisting of the following (a), (b) and (c):
(a) sulfosalicylic acid or its salt,
(b) 0.2 to 10.0 g/L of a water-soluble chelating agent having a nitrogen atom and a carboxyl group, and
(c) piperazine or its salt, and
(3) a buffer for maintaining pH at 4 to 6.
5. A reagent for measurement of blood leukocyte counts and hemoglobin concentration in blood, said reagent consisting essentially of:
( 1 ) one or more cationic surfactants in an amount effective to lyse erythrocytes and denature hemoglobin,
( 2 ) 0 . 2 to 10 . 0 g/L of a water soluble chelating agent having a nitrogen atom and a carboxyl group, and
( 3 ) a buffer for maintaining pH at 4 to 6 .
6. A reagent for measurement of blood leukocyte counts and hemoglobin concentrations by conversion to methemoglobin, said reagent comprising:
( 1 ) one or more cationic surfactants in an amount effective to lyse erythrocytes and denature hemoglobin,
( 2 ) 0 . 2 to 10 . 0 g/L of a water soluble chelating agent having a nitrogen atom and a carboxyl group, said chelating agent being present in a total amount sufficient to convert the hemoglobin to methemoglobin, and
( 3 ) a buffer for maintaining pH at 4 to 6 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.